Sun, Apr 20, 2014, 2:13 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

RXi Pharmaceuticals Corporation Message Board

  • red900901 red900901 Apr 5, 2013 4:50 PM Flag

    "37% Average Reduction in Scar Tissue Observed - Exciting Scar Reduction Activity Observed in Two Phase 1 RXI-109 Clinical Studies"


    "During the recent 2013 BIO CEO Conference, which took place in New York City, RXi Pharmceuticals presented new exciting preliminary blinded data for RXI-109 from their scar prevention and reduction studies. Noticeable reductions in scar tissue were observed in two studies and there appears to be a clear correlation between CTGF expression and scar area, providing strong evidence of the mechanism of action."

    Source: lifesciadvisors.c*m/clientinfo/rxi/RXi__BIO_CEO_2-14-13__clientinfo.pdf

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.51+0.08(+2.33%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST